203 related articles for article (PubMed ID: 24139518)
1. Transforming growth factor β-1 (TGF-β1) is a serum biomarker of radiation induced fibrosis in patients treated with intracavitary accelerated partial breast irradiation: preliminary results of a prospective study.
Boothe DL; Coplowitz S; Greenwood E; Barney CL; Christos PJ; Parashar B; Nori D; Chao KS; Wernicke AG
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1030-6. PubMed ID: 24139518
[TBL] [Abstract][Full Text] [Related]
2. Tissue compliance meter is a more reproducible method of measuring radiation-induced fibrosis than late effects of normal tissue-subjective objective management analytical in patients treated with intracavitary brachytherapy accelerated partial breast irradiation: results of a prospective trial.
Wernicke AG; Greenwood EA; Coplowitz S; Parashar B; Kulidzhanov F; Christos PJ; Fischer A; Nori D; Chao KS
Breast J; 2013; 19(3):250-8. PubMed ID: 23614363
[TBL] [Abstract][Full Text] [Related]
3. Assessment of pain as a sequela in patients treated with intracavitary brachytherapy accelerated partial breast irradiation (IBAPBI): preliminary results of a prospective study.
Greenwood EA; Coplowitz S; Patel P; Sharma N; Kulidzhanov F; Christos PJ; Fischer A; Parashar B; Nori D; Chao KS; Wernicke AG
Breast J; 2013; 19(6):595-604. PubMed ID: 24102810
[TBL] [Abstract][Full Text] [Related]
4. The comparison of transforming growth factor beta-1 serum levels in early-stage breast cancer patients treated with external beam whole breast irradiation plus boost versus interstitial brachytherapy accelerated partial breast irradiation.
Hosseini SM; Mohammadi MK; Bagheri A; Arvandi S; Shahbazian H; Mohammadian F
Brachytherapy; 2022; 21(6):748-753. PubMed ID: 36167654
[TBL] [Abstract][Full Text] [Related]
5. Accelerated partial breast irradiation with low-dose-rate interstitial implant brachytherapy after wide local excision: 12-year outcomes from a prospective trial.
Hattangadi JA; Powell SN; MacDonald SM; Mauceri T; Ancukiewicz M; Freer P; Lawenda B; Alm El-Din MA; Gadd MA; Smith BL; Taghian AG
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):791-800. PubMed ID: 22099046
[TBL] [Abstract][Full Text] [Related]
6. TGF-beta1 levels in pre-treatment plasma identify breast cancer patients at risk of developing post-radiotherapy fibrosis.
Li C; Wilson PB; Levine E; Barber J; Stewart AL; Kumar S
Int J Cancer; 1999 Apr; 84(2):155-9. PubMed ID: 10096248
[TBL] [Abstract][Full Text] [Related]
7. Quantitative assessment of radiation-induced fibrosis of the breast with tissue compliance meter, palpation, and radiological imaging: preliminary results.
Wernicke AG; Rosenblatt R; Rasca M; Parhar P; Christos PJ; Fischer A; Parashar B; Nori D
Breast J; 2009; 15(6):583-92. PubMed ID: 19824999
[TBL] [Abstract][Full Text] [Related]
8. Partial breast irradiation with interstitial 60CO brachytherapy results in frequent grade 3 or 4 toxicity. Evidence based on a 12-year follow-up of 70 patients.
Póti Z; Nemeskéri C; Fekésházy A; Sáfrány G; Bajzik G; Nagy ZP; Bidlek M; Sinkovics I; Udvarhelyi N; Liszkay G; Repa I; Galuska L; Trón L; Mayer A; Esik O
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1022-33. PubMed ID: 15001241
[TBL] [Abstract][Full Text] [Related]
9. The predictive role of plasma TGF-beta1 during radiation therapy for radiation-induced lung toxicity deserves further study in patients with non-small cell lung cancer.
Zhao L; Sheldon K; Chen M; Yin MS; Hayman JA; Kalemkerian GP; Arenberg D; Lyons SE; Curtis JL; Davis M; Cease KB; Brenner D; Anscher MS; Lawrence TS; Kong FM
Lung Cancer; 2008 Feb; 59(2):232-9. PubMed ID: 17905467
[TBL] [Abstract][Full Text] [Related]
10. Plasma Levels of IL-8 and TGF-β1 Predict Radiation-Induced Lung Toxicity in Non-Small Cell Lung Cancer: A Validation Study.
Wang S; Campbell J; Stenmark MH; Zhao J; Stanton P; Matuszak MM; Ten Haken RK; Kong FS
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(3):615-621. PubMed ID: 28581403
[TBL] [Abstract][Full Text] [Related]
11. Association of Transforming Growth Factor β Polymorphism C-509T With Radiation-Induced Fibrosis Among Patients With Early-Stage Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial.
Grossberg AJ; Lei X; Xu T; Shaitelman SF; Hoffman KE; Bloom ES; Stauder MC; Tereffe W; Schlembach PJ; Woodward WA; Buchholz TA; Smith BD
JAMA Oncol; 2018 Dec; 4(12):1751-1757. PubMed ID: 30027292
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor beta 1 levels predict echocardiographic changes at three years after adjuvant radiotherapy for breast cancer.
Aula H; Skyttä T; Tuohinen S; Luukkaala T; Hämäläinen M; Virtanen V; Raatikainen P; Moilanen E; Kellokumpu-Lehtinen PL
Radiat Oncol; 2019 Aug; 14(1):155. PubMed ID: 31470867
[TBL] [Abstract][Full Text] [Related]
13. Blood gene expression profiling of breast cancer survivors experiencing fibrosis.
Landmark-Høyvik H; Dumeaux V; Reinertsen KV; Edvardsen H; Fosså SD; Børresen-Dale AL
Int J Radiat Oncol Biol Phys; 2011 Mar; 79(3):875-83. PubMed ID: 21129856
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of predictive and prognostic significance of serum TGF-beta1 levels in breast cancer according to HER-2 codon 655 polymorphism.
Papadopoulou E; Anagnostopoulos K; Tripsianis G; Tentes I; Kakolyris S; Galazios G; Sivridis E; Simopoulos K; Kortsaris A
Neoplasma; 2008; 55(3):229-38. PubMed ID: 18348656
[TBL] [Abstract][Full Text] [Related]
15. Complication probability model for subcutaneous fibrosis based on published data of partial and whole breast irradiation.
Avanzo M; Stancanello J; Trovò M; Jena R; Roncadin M; Trovò MG; Capra E
Phys Med; 2012 Oct; 28(4):296-306. PubMed ID: 22119271
[TBL] [Abstract][Full Text] [Related]
16. TGF-beta1 in serum and induced sputum for predicting radiation pneumonitis in patients with non-small cell lung cancer after radiotherapy.
Wang J; Qiao XY; Lu FH; Zhou ZG; Song YZ; Huo JJ; Liu X
Chin J Cancer; 2010 Mar; 29(3):325-9. PubMed ID: 20193119
[TBL] [Abstract][Full Text] [Related]
17. Randomized trial of pentoxifylline and vitamin E vs standard follow-up after breast irradiation to prevent breast fibrosis, evaluated by tissue compliance meter.
Jacobson G; Bhatia S; Smith BJ; Button AM; Bodeker K; Buatti J
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):604-8. PubMed ID: 22846413
[TBL] [Abstract][Full Text] [Related]
18. The Role of Signal Transducer and Activator of Transcription 5 and Transforming Growth Factor-β1 in Hepatic Fibrosis Induced by Chronic Hepatitis C Virus Infection in Egyptian Patients.
Abu El Makarem MA; El-Sagheer GM; Abu El-Ella MA
Med Princ Pract; 2018; 27(2):115-121. PubMed ID: 29402841
[TBL] [Abstract][Full Text] [Related]
19. Serum levels of transforming growth factor beta1 in patients with breast cancer.
Sheen-Chen SM; Chen HS; Sheen CW; Eng HL; Chen WJ
Arch Surg; 2001 Aug; 136(8):937-40. PubMed ID: 11485532
[TBL] [Abstract][Full Text] [Related]
20. TLD skin dose measurements and acute and late effects after lumpectomy and high-dose-rate brachytherapy only for early breast cancer.
Perera F; Chisela F; Stitt L; Engel J; Venkatesan V
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1283-90. PubMed ID: 16029783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
